MillerLW, GuglinM: Patient selection for ventricular assist devices: A moving target. J Am Coll Cardiol, 2013; 61:1209–1221.
2.
KirklinJK, NaftelDC, PaganiI, et al.: Sixth INTERMACS annual report: A 10,000-patient database. J Heart Lung Transplant, 2014; 33:555–564.
3.
CopelandJG, SmithRG, ArabiaFA, et al.: Cardiac replacement with a total artificial heart as a bridge to transplantation. N Engl J Med, 2004; 351:859–867.
4.
CopelandJG, SmithRG, ArabiaFA, et al.: Total artificial heart bridge to transplantation: A 9-year experience with 62 patients. J Heart Lung Transplant, 2004; 23:823–831.
5.
LeprinceP, BonnetN, RamaA, et al.: Bridge to transplantation with the Jarvik-7 (CardioWest) total artificial heart: A single center 15-year experience. J Heart Lung Transplant, 2003; 22:1296–1303.
6.
RadyMY, VerheijdeJL: Ethical challenges with deactivation of durable mechanical circulatory support at the end of life: Left ventricular assist devices and total artificial hearts. J Intensive Care Med, 2014; 29:3–12.
7.
BruceCR, AllenNG, FahyBN, et al.: Challenges in deactivating a total artificial heart for a patient with capacity. Chest, 2014; 145:625–631.
8.
MuellerPS, SwetzKM, FreemanMR, et al.: Ethical analysis of withdrawing ventricular assist device support. Mayo Clin Proc, 2010; 85:791–797.
